ImmunXperts

Foundation date

15/05/2014

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

ImmunXperts offers a wide range of in silico and in vitro assays to companies developing new drugs. The purpose of these tests is to help our partners select the best and less risky drug candidates before further development into the clinical phases. We want to be a trusted partner for our clients by thinking and working together; acting as their mobile development team in the areas where they need us.

Latest news

  • Antonin (Tony) de Fougerolles appointed as new Chair of etherna

    Tuesday July 16th 2024

  • ONTOFORCE Achieves ISO 27001:2022 Certification: A Milestone in Information Security and Trust

    Tuesday July 16th 2024

  • Ghent University spin-off Trince wins Nature Spinoff Prize

    Monday July 15th 2024